Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
platelet rich fibrin + simvastatin
- Development stage
- Preclinical
- Lead developer
- Choukroun et al.
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
- Administration
- Topical, Surgical Implantation
01
Overview
Platelet rich fibrin + simvastatin is a combination therapy that merges two distinct agents for enhanced tissue regeneration and healing. Platelet-rich fibrin (PRF) is an autologous blood-derived biomaterial containing a dense network of platelets, leukocytes, cytokines, and growth factors within a three-dimensional fibrin matrix. PRF acts as a scaffold to support wound healing and tissue regeneration by gradually releasing growth factors such as PDGF, TGF-β, VEGF, and EGF over time[1][2][4][5]. Simvastatin is a synthetic statin class small molecule that inhibits HMG-CoA reductase to lower cholesterol but also exhibits pleiotropic effects including anti-inflammatory activity and promotion of bone formation. The combination has been explored in regenerative medicine—especially dentistry—for synergistic effects on bone regeneration and soft tissue repair.
- Other names
- PRF + simvastatinplatelet-rich fibrin plus simvastatin
02
Targets
HMGCR (3-hydroxy-3-methylglutaryl-coenzyme A reductase)TGFBR (TGF-beta receptor)VEGFR (VEGFR family)PDGFR (PDGFR family)
Beyond the preview
Go deeper on platelet rich fibrin + simvastatin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on platelet rich fibrin + simvastatin.